Ownership history in RENAISSANCE TECHNOLOGIES LLC · 39 quarters on record
This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in ADAPTIMMUNE THERAPEUTICS PLC (ADAP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 4,054,089 | +2,171,229 | +115.3% | 0.00% | $527K | — |
| 2025 Q2 | ADDED | 1,882,860 | +69,000 | +3.8% | 0.00% | $451K | — |
| 2025 Q1 | REDUCED | 1,813,860 | -712,664 | -28.2% | 0.00% | $357K | — |
| 2024 Q4 | ADDED | 2,526,524 | +869,949 | +52.5% | 0.00% | $1.4M | — |
| 2024 Q3 | REDUCED | 1,656,575 | -129,766 | -7.3% | 0.00% | $1.6M | — |
| 2024 Q2 | ADDED | 1,786,341 | +394,566 | +28.3% | 0.00% | $1.7M | — |
| 2024 Q1 | ADDED | 1,391,775 | +21,536 | +1.6% | 0.00% | $2.2M | — |
| 2023 Q4 | ADDED | 1,370,239 | +342,379 | +33.3% | 0.00% | $1.1M | — |
| 2023 Q3 | REDUCED | 1,027,860 | -478,515 | -31.8% | 0.00% | $802K | — |
| 2023 Q2 | ADDED | 1,506,375 | +1,323,675 | +724.5% | 0.00% | $1.4M | — |
As of 2025 Q4 — sorted by position size